
|Videos|May 26, 2022
Dose Reductions and Treatment Breaks on Lenvatinib Therapy
Author(s)Tom Powles, MBBS, MRCP, MD, Brian Shimkus, MD
Dr Brian Shimkus describes how he doses lenvatinib for renal cell carcinoma treatment.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
2026 Tandem Meetings: Whatโs the Latest Research in Multiple Myeloma?
3
Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma
4
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
5















































